Patents by Inventor Caurnel Morgan

Caurnel Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of melanocortin receptors for the treatment of depression and anxiety
    Patent number: 11542302
    Abstract: Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand according to the following: in a pharmaceutically acceptable carrier is administered to the subject. Xaa can be Cha or Pro. The MC5R peptide is a selective MC5R antagonist, and administration thereof to the subject can treat the depressive or anxiety disorder with clinical improvement observed in a relatively short time.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: January 3, 2023
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Victor J. Hruby, Minying Cai, Caurnel Morgan
  • NOVEL MODULATORS OF MELANOCORTIN RECEPTORS FOR THE TREATMENT OF DEPRESSION AND ANXIETY
    Publication number: 20200277331
    Abstract: Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand according to the following: in a pharmaceutically acceptable carrier is administered to the subject. Xaa can be Cha or Pro. The MC5R peptide is a selective MC5R antagonist, and administration thereof to the subject can treat the depressive or anxiety disorder with clinical improvement observed in a relatively short time.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Inventors: Victor J. Hruby, Minying Cai, Caurnel Morgan
  • Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
    Patent number: 10653743
    Abstract: Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising compound PG-20N in a pharmaceutically acceptable carrier is described. According to another embodiment, the subject disclosure features method of treating a depressive disorder or an anxiety disorder in a subject in need of such treatment. The method may comprise administering to the subject a therapeutically effective amount of a composition comprising PG-20N.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: May 19, 2020
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Victor J. Hruby, Minying Cai, Caurnel Morgan
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION AND ANXIETY
    Publication number: 20180311304
    Abstract: Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising compound PG-20N in a pharmaceutically acceptable carrier is described. According to another embodiment, the subject disclosure features method of treating a depressive disorder or an anxiety disorder in a subject in need of such treatment. The method may comprise administering to the subject a therapeutically effective amount of a composition comprising PG-20N.
    Type: Application
    Filed: October 17, 2016
    Publication date: November 1, 2018
    Inventors: Victor J. Hruby, Minying Cai, Caurnel Morgan